Trial Summary
What is the purpose of this trial?
The purpose of the study is to ascertain whether traditional kefir not only enhances vascular health but also contributes to improved immune outcomes in both male and female participants at higher risk or living with Type 2 Diabetes (T2D) after 12 weeks of treatment.
Research Team
BW
Benjamin Willing, PhD
Principal Investigator
University of Alberta
Eligibility Criteria
This trial is for men and women at high risk of or living with Type 2 Diabetes who may also have cardiovascular issues. Participants should be interested in testing if kefir can improve their vascular health and immune system over a 12-week period.Inclusion Criteria
My blood sugar or HbA1C levels indicate I'm at high risk for type 2 diabetes.
I have been diagnosed with Type 2 Diabetes.
Overweight or obesity (BMI >25 for Caucasian, >23 for Asian)
See 1 more
Exclusion Criteria
Being pregnant or breastfeeding
I haven't taken antibiotics, steroids, or immune-suppressing drugs in the last 3 months.
Usual high intake (maximum intake 3 servings/week) of fermented foods excluding cheese (i.e., kefir, kombucha, kimchi, etc.) for the past 3 months
See 4 more
Treatment Details
Interventions
- Traditional Kefir (Probiotic)
Trial OverviewThe study is examining the effects of traditional kefir compared to milk (which serves as a placebo) on vascular and immune health outcomes in individuals with or at high risk for Type 2 Diabetes.
Participant Groups
2Treatment groups
Experimental Treatment
Group I: Participants with higher risk of T2DExperimental Treatment2 Interventions
Randomly assigned to consume either traditional kefir or milk as a placebo.
Group II: Participants living with T2DExperimental Treatment2 Interventions
Randomly assigned to consume either traditional kefir or milk as a placebo.
Find a Clinic Near You
Research Locations NearbySelect from list below to view details:
Human Nutrition Research Unit (HNRU)Edmonton, Canada
Loading ...
Who Is Running the Clinical Trial?
University of Alberta
Lead Sponsor
Trials
957
Patients Recruited
437,000+